Sangel Capital Investor
one of the earliest globally operating professional biomedical venture capital institutions in China
Headquarters:
Shenzhen, Guangdong, China
Funding Status:
Private
Investor Type:
Venture Capital
Investment Stage:
Early Stage Venture, Seed
Number Of Exits:
1
Investors Number:
25
Register and Claim Ownership